Research shows how RNA ‘junk’ controls our genes

New study explores the machinery of gene regulation: The tiny roundworm C.elegans is the focus of a new study examining 3’UTRs. These short segments of RNA play a critical role in the regulation of genes. The resulting map, the product of 20 years of research, is the most complete dataset of its kind for any animal, and will help advance basic understanding of mechanisms of gene regulation critical in human health and disease. Continue reading

KEYS Research Internship welcomes newest cohort for summer 2024

The KEYS (Keep Engaging Youth in Science) Research Internship Program at the University of Arizona BIO5 Institute has launched its 2024 cohort, marking the beginning of a transformative summer experience for high school students across Arizona. The program officially commenced on June 3 with an intensive training week designed to equip interns with essential research and professional skills.  Continue reading

Tucson Eye Care Company iCRx Joins UA Tech Park

TUCSON, Ariz. – iCRx, a leader in eye care innovation through optic technology, announced today its move to the University of Arizona (UA) Tech Park. Their new facility includes office and laboratory space that enable cutting-edge optical research. This announcement is a milestone for the Tucson-based company as it prepares to unveil its groundbreaking One-Minute Eye Exam technology.Continue reading

Innovative Nevada Based Company Focused on Developing Patented Therapeutic and Pharmaceutical Formulations with Enhanced Efficacy Wins Incubation Support through the University of Arizona in Collaboration with Oro Valley

TUCSON, AZ. — The University of Arizona Center for Innovation (UACI) is pleased to announce the winning company for the UACI Sponsored Launch Fueled by the Oro Valley Chamber of Commerce and Town of Oro Valley competition. CellMedics Inc., will receive support in the UACI incubation program including resources, facilities, services and expert guidance to grow its business.Continue reading

Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial

PHOENIX, June 3, 2024 /PRNewswire/ — Calviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study (VACCS) on May 4, 2024; a five-year clinical trial investigating a novel preventative cancer vaccine in dogs. This multi-center, double-blind, placebo-controlled study, the largest of its kind in veterinary oncology, represents a significant milestone in the fight against canine cancer.Continue reading